Market revenue in 2023 | USD 8,068.2 million |
Market revenue in 2030 | USD 12,103.7 million |
Growth rate | 6% (CAGR from 2023 to 2030) |
Largest segment | Tablets |
Fastest growing segment | Capsules |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Tablets, Capsules, Powders, Granules |
Key market players worldwide | Catalent Inc, Lonza Group Ltd, Boehringer Ingelheim, Jubilant Pharmova, Novacyt SA, Thermo Fisher Scientific Inc, Recipharm, CordenPharma, Siegfried Holding AG, Piramal Pharma Solutions, AbbVie Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to oral solid dosage contract manufacturing market will help companies and investors design strategic landscapes.
Tablets was the largest segment with a revenue share of 31.99% in 2023. Horizon Databook has segmented the Europe oral solid dosage contract manufacturing market based on tablets, capsules, powders, granules covering the revenue growth of each sub-segment from 2018 to 2030.
Europe held the third-largest share of the global oral solid dosage contract manufacturing market in 2023 owing to the presence of reputed pharmaceutical companies in this region. Europe has a robust pharmaceutical sector with numerous drug discoveries, development, and manufacturing companies. The growing number of pharmaceutical activities increases the demand for CMOs.
The growing number of pharmaceutical activities increases the demand for CMOs. The surge in demand for sophisticated oral solid dosage encourages these industries to seek support from CMOs.
Consequently, the region benefits from access to large treatment-naïve patient pools, a highly skilled medical research workforce, well-defined research guidelines, and favorable conditions such as low labor & manufacturing costs, which is expected to contribute to the market growth.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe oral solid dosage contract manufacturing market , including forecasts for subscribers. This continent databook contains high-level insights into Europe oral solid dosage contract manufacturing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account